![Manuel Litchman](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Manuel Litchman
Chief Executive Officer at
MUSTANG BIO, INC.
Net worth: 869 $ as of 2026-08-30
Profile
Manuel Litchman is President, CEO, CFO & Director at Mustang Bio, Inc. since 2024.
Formerly, Dr. Litchman was President, Chief Executive Officer & Director at Arvinas Operations, Inc., Principal at F.
Hoffmann-La Roche Ltd., and VP & Head-Oncology Business Development at Novartis Pharmaceuticals Corp.
from 2012 to 2014.
Education includes undergraduate studies at Princeton University and a doctorate from Yale School of Medicine.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
MUSTANG BIO, INC. 0.02% | 2026-04-23 | 1,615 ( 0.02% ) | 869 $ | 2026-08-30 |
Manuel Litchman active positions
| Companies | Position | Start |
|---|---|---|
| MUSTANG BIO, INC. | Chief Executive Officer | 2017-04-23 |
Former positions of Manuel Litchman
| Companies | Position | End |
|---|---|---|
Novartis Pharmaceuticals Corp.
 Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Manufactures medicines and provides healthcare solutions | Corporate Officer/Principal | 2014-11-30 |
F. Hoffmann-La Roche Ltd.
 F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Corporate Officer/Principal | - |
Arvinas Operations, Inc.
 Arvinas Operations, Inc. BiotechnologyHealth Technology Develops protein degradation therapeutics for cancer and other diseases | Chief Executive Officer | - |
Training of Manuel Litchman
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
41
1st degree connections
6
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 6 |
|---|---|
F. Hoffmann-La Roche Ltd.
F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Arvinas Operations, Inc.
Arvinas Operations, Inc. BiotechnologyHealth Technology Develops protein degradation therapeutics for cancer and other diseases | Health Technology |
Princeton University
 Princeton University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novartis Pharmaceuticals Corp.
Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Manufactures medicines and provides healthcare solutions | Health Technology |
Yale School of Medicine
 Yale School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Mustang Bio, Inc.
 Mustang Bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage biopharmaceutical company which develops novel immunotherapy''s | Health Technology |
- Stock Market
- Insiders
- Manuel Litchman
